MASTINO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 14.499
EU - Europa 12.944
AS - Asia 6.625
SA - Sud America 2.704
Continente sconosciuto - Info sul continente non disponibili 218
AF - Africa 206
OC - Oceania 18
Totale 37.214
Nazione #
US - Stati Uniti d'America 14.180
RU - Federazione Russa 6.378
SG - Singapore 2.861
BR - Brasile 2.323
CN - Cina 1.962
IE - Irlanda 1.604
SE - Svezia 1.178
UA - Ucraina 895
IT - Italia 737
DE - Germania 681
HK - Hong Kong 627
FI - Finlandia 386
FR - Francia 385
VN - Vietnam 365
GB - Regno Unito 239
PL - Polonia 181
IN - India 147
AR - Argentina 124
CA - Canada 124
BD - Bangladesh 91
MX - Messico 78
TR - Turchia 78
IQ - Iraq 73
EC - Ecuador 66
ZA - Sudafrica 60
CO - Colombia 56
ID - Indonesia 51
PK - Pakistan 50
UZ - Uzbekistan 50
CZ - Repubblica Ceca 49
MA - Marocco 48
VE - Venezuela 47
BE - Belgio 42
NL - Olanda 35
CL - Cile 28
JP - Giappone 28
IL - Israele 26
AT - Austria 25
KR - Corea 25
KE - Kenya 21
RO - Romania 21
TN - Tunisia 21
UY - Uruguay 21
AZ - Azerbaigian 20
CR - Costa Rica 16
IR - Iran 16
NP - Nepal 16
PE - Perù 16
AE - Emirati Arabi Uniti 15
ES - Italia 15
PY - Paraguay 15
CW - ???statistics.table.value.countryCode.CW??? 14
DZ - Algeria 14
EG - Egitto 14
HN - Honduras 14
OM - Oman 14
PH - Filippine 14
SA - Arabia Saudita 14
JO - Giordania 13
TT - Trinidad e Tobago 12
AL - Albania 11
LT - Lituania 11
JM - Giamaica 10
KZ - Kazakistan 10
MY - Malesia 10
NI - Nicaragua 10
NZ - Nuova Zelanda 10
PA - Panama 10
EU - Europa 9
GP - Guadalupe 9
LB - Libano 9
PR - Porto Rico 9
AU - Australia 8
CI - Costa d'Avorio 8
EE - Estonia 8
BO - Bolivia 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
RS - Serbia 7
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
AM - Armenia 5
BG - Bulgaria 5
BY - Bielorussia 5
GT - Guatemala 5
PT - Portogallo 5
AO - Angola 4
GE - Georgia 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
MK - Macedonia 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BN - Brunei Darussalam 3
ET - Etiopia 3
NG - Nigeria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 36.978
Città #
Moscow 1.996
Ashburn 1.790
Jacksonville 1.682
Dublin 1.604
Singapore 1.523
Dallas 1.398
Chandler 1.231
San Jose 771
Beijing 727
Nyköping 708
Council Bluffs 627
Hong Kong 627
The Dalles 367
Princeton 322
Los Angeles 316
Cambridge 313
Lauterbourg 299
Dearborn 264
Des Moines 258
Medford 226
Boardman 201
Ann Arbor 189
Messina 180
Warsaw 173
São Paulo 159
Buffalo 158
New York 135
Ho Chi Minh City 127
Munich 109
Tianjin 101
Columbus 95
Rome 93
Rio de Janeiro 78
Jinan 71
Santa Clara 70
Hanoi 69
Wilmington 69
Guangzhou 63
Shenyang 59
Woodbridge 58
Redondo Beach 55
San Mateo 53
Orem 52
Turku 49
Belo Horizonte 47
Nanjing 47
Shanghai 44
Tashkent 44
Brooklyn 39
Brussels 39
Frankfurt am Main 39
Brasília 36
Houston 35
Phoenix 35
Washington 35
Atlanta 33
Hangzhou 33
Pune 33
Montreal 31
Porto Alegre 31
Chicago 30
Curitiba 30
Olomouc 29
Baghdad 27
Johannesburg 27
Ningbo 27
Tokyo 27
Campinas 26
Helsinki 26
Milan 26
Norwalk 26
Santo André 26
Turin 26
Boston 25
Chennai 25
Goiânia 25
Quito 25
Salvador 25
Zhengzhou 25
Denver 24
Mexico City 24
Amsterdam 23
Shenzhen 23
Stockholm 23
Guarulhos 22
Guayaquil 21
Haikou 21
Ribeirão Preto 21
San Francisco 21
Baku 20
London 20
Fortaleza 19
Seattle 19
Sorocaba 19
Toronto 19
Bogotá 18
Jakarta 18
Manaus 18
North Bergen 18
Brno 17
Totale 21.047
Nome #
4 '-alpha-C-branched N,O-nucleosides: synthesis and biological properties 233
Analoghi nucleosidici ad attività antivirale 228
Early activation of MyD88-mediated autophagy sustains HSV-1 replication in human monocytic THP-1 cells 228
HSV-1EGFP stimulates miR-146a expression in a NF-κB-dependent manner in monocytic THP-1 cells 228
3-amino-2(5H) furanones as inhibitors of subgenomic hepatitis C virus RNA replication 221
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity. 211
Role of ERK1/2 protein in the regulation of Herpes simplex virus type I replicative cycle 207
Permissiveness of THP-1 monocytic cells to HSV-1 infection: role of the autophagic pathway 206
Ruolo della proteina virale vhs nel controllo della risposta innata cellulare mediata da PKR durante l’infezione da HSV-1. 205
HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis 204
REGOLAZIONE DELLE MAP-CHINASI NELL’INFEZIONE DA VIRUS HERPES SIMPLEX DI TIPO 1: RUOLO DELLA PROTEINA VIRALE VHS. 202
L’aumento della resa virale e dell’apoptosi in cellule monocitiche infettate da HSV-1 a seguito di inibizione di NF-kB non dipende dalla regolazione trascrizionale di TNF-α o IFN 199
Il fattore di trascrizione nucleare kappa b gioca un ruolo nell’immunità innata nei confronti dell’ infezione da HSV-1 in cellule monocitiche U937. 198
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 194
Antiviral activity of seed extract from Citrus bergamia towardshuman retroviruses 193
Activation of NF-KB in the very-early phase of HSV-1 infection: role of glycoprotein D/HveA interaction 192
Effect of interference with apoptosis on HSV-2 replication in monocytoid U937 cells 190
Role of NF-kappa B transcription factor in innate response to HSV-1 infection of monocytic U937 cells 189
HERPES SIMPLEX VIRUS TYPE I DELETED IN VHS GENE: PERMISSIVENESS MADIATED BY CELLULAR PROTEIN MEK 189
Anti-herpes simplex virus 1 and immunomodulatory activities of a poly-g- glutamic acid from Bacillus horneckiae strain APA of shallow vent origin 188
Coinvolgimento del recettore HVEM nell'attivazione di NF-kB da parte della glicoproteina D di HSV-1 186
NF-ΚB-dependent production of ROS and restriction of HSV-1 infection in U937 monocytic cells 186
Recruitment of MyD88 in the early phases of HSV-1 infection 183
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD 182
Engagement of HSV-1 gD with HVEM cellular receptor induces NF-kB activation. 181
Analisi della restrizione virale su cellule VERO infettate da HSV-2 mediata da anticorpi di classe A polimeriche a moderata avidità 181
Inhibition of NF-kappaB activation enhances HSV-1 replication in U937 cells 180
La risposta innata nelle infezioni virali: ruolo del fattore nucleare kappa B. 179
Apoptosi e Virus. 178
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview 178
STUDI SUL RUOLO DI NF-KAPPA B E DELL’APOPTOSI NELL’ INFEZIONE DI CELLULE U937 DA PARTE DI HSV-1. 177
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s disease. 177
Caspase-8 is required for HSV-1-induced apoptosis and promotes effective viral particle release via autophagy inhibition 176
Bcl-2 overexpression overcomes the incapability of monocytoid cells to sustain a fully-productive infection by HSV-2. 176
Forced expression of HveA renders cells sensitive to NF-kB activation by UV-inactivated HSV-1 or HSV-1 glycoprotein D. 175
AZT treatment potentiates apoptosis induction by NF-kB inhibitors in HTLV-1 infected cells 174
L'infezione di linee cellulari permissive da parte di Bovine Herpesvirus-4 è associata ad induzione di apoptosi. 174
Knockdown of Bcl-2 by siRNA abolishes the permissiveness state of HeLa cells to HSV-2 infection. 173
Herpes simplex virus and cell apoptotic response 173
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α 173
A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells 172
Signaling activity by herpes simplex virus: molecular mechanisms and biotechnological implications 172
L'over-espressione del protooncogene bcl-2 rende le cellule monocitoidi U937 pienamente permissive all'infezione da HSV-2. 170
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 170
Meccanismi molecolari di regolazione genica del virus herpes simplex: nuove acquisizioni sul ruolo delle proteine virali VP22 e VHS 168
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity 167
Involvement of HVEM receptor in activation of nuclear factor KB by HSV-1 glycoprotein D. 167
A novel, PCR-based for evaluating the HIV-RT inhibitory activity of antiretroviral compounds 167
Il silenziamento del protooncogene Bcl-2 mediante siRNA rende le cellule HeLa non permissive all'infezione da HSV-2. 165
Ruolo dell'interazione glicoproteina D/recettore HVEA nell'attivazione precoce di NF-kB da parte di HSV-1. 165
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSVA gD. 165
L’ ATTIVAZIONE DI NF-KAPPA B E’ ASSOCIATA ALLA PARZIALE RESTRIZIONE DELL’ INFEZIONE DA HSV-1 IN CELLULE U937. 164
Alterations in leukocyte rheology and atherosclerotic disease 161
HVEM-mediated activationof nuclear factor kB by HSV-1 glycoprotein D. 161
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol 161
L'induzione di apoptosi in cellule BEK da parte di BoHV-4 è associata ad inibizione dell'espressione di Bcl-2 ed attivazione di CPP32 160
L'induzione di apoptosi in cellule BEK da parte di BoHV-4 è associata ad inibizione dell'espressione di Bcl-2 ed attivazione di CPP32 160
Development and evaluation of a simple and effective RT-qPCR inhibitory assay for detection of the efficacy of compounds towards HIV reverse transcriptase 159
Key role of Bcl-2 expression for productive HSV-2 replication. 157
Role of herpesvirus entry Receptor A in replication-indipendent NF-kB activation by HSV-1. 155
The virion host shut-off RNase plays a key role in blocking the activation of Protein kinase R in cells infected with Herpes Simplex Virus 1 155
Eziopatogenesi dell’infezione da herpes simplex: ruolo delle IgA e dell’apoptosi 154
Comparison of an enzyme immunoassay versus a rapid latex test for serodiagnosis of Helicobacter pylori infection 153
Activation of human endogenous retrovirus-K and production of infectious viral-like particles in human melanoma cells. 153
Expression of genes encoding innate antiviral response in human monocytic cells, transfected or not with a dominant negative NF-kappa-B, following HSV-1 infection . 152
Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells 151
Preparation of phosphonated isoxazolidinyl nucleoside analogs with antiviral activity. 150
Signaling cellulare ed infezione da virus herpes simplex. 150
A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptase. 150
ISOLATI DI HSV-1 DELETI NEL GENE UL-49 IN GRADO DI DARE LUOGO AD INFEZIONE PRODUTTIVA, GENERATI CON IL SISTEMA BAC-DNA, PRESENTANO NECESSARIAMENTE MUTAZIONI SPONTANEE NELLA PROTEINA VHS (UL41) 149
Induzione di apoptosi in cellule di rene embrionale bovino (BEK) infettate da Bovine Herpesvirus-4 (BoHV-4) 148
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB 147
Future perspectives on drug targeting in adult T cell leukemia-lymphoma 147
[Effect of thymosin alpha 1 on prostaglandin release by murine lymphocytes]. 146
Role of Caspase-8 in HSV-1 induced cell death 146
Effects of a seed extract from citrus bergamia on human retrovirus infection in vitro 145
(−)-(1R,2R,7S,8aR)-1,2,7-Trihydroxyindolizidine ((−)-7S-OH-Lentiginosine): Synthesis and Proapoptotic Activity 143
Apoptosis induced by HSV-1 requires BH3-only protein Puma and p73. 143
Caratterizzazione del fenomeno di apoptosi indotto da HHV-2 in cellule monocitoidi U937 142
Effect of nucleoside inhibitors on activation of cell death. 140
Nucleoside analogues with antiviral activity 140
Binding of herpes simplex virus 1 to HVEM receptor through envelope glycoprotein D ensures protection against apoptosis. 140
[Effect of alpha-1-thymosin on intracellular cyclic AMP in mouse thymic subpopulations]. 139
D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent 139
Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the U(L)49 gene vary with respect to the defect in the U(L)41 gene encoding host shutoff RNase 138
NF-kB-dependent Protection From Apoptosis by HSV-1 gD/HVEM Interaction. 138
[Relation between thymosin fraction 5, prostaglandin release and Thy-1 antigen appearance in mice lymphocytes]. 136
Lysosomal membrane permeabilization is involved in apoptosis induced by HSV-1 in monocytic cells 136
Testing anti-HIV activity of antiretroviral agents in vitro using infection of CEM-GFP cells with an HIV-1 NL4-3 recombinant strain and flow cytometry. 136
Signaling Pathway Utilized by HSV-1 to Induce NF-kB Activation: Possible Role of Herpesvirus Entry Receptor A. 136
Crosstalk between autophagy and apoptosis during HSV-1 replication: possible role of Us11 viral protein 134
Signaling pathway utilized by HSV-1 to induce NF-kB activation: possible role of herpesvirus entry receptor A. 134
[Effects of an antiserum for epithelial-reticular cells of the thymus on T-dependent immune response]. 134
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3 134
Inhibition of NF-kB activation sensitizes U937 cells to 3’-azido-3’-deoxythymidine (AZT) induced apoptosis 133
Dysregulated NF-κB pathway in peripheral mononuclear cells of Alzheimer's disease patients. 133
ANTIVIRAL AZANUCLEOSIDE DERIVATIVES 132
[Effects of thymosin alpha l on some time-dependent functions in thymectomized mice]. 131
[Immunomodulating action of prostaglandins]. 130
Synthesis and biological evaluation of phosphonated dihydroisoxazole nucleosides 128
Totale 16.618
Categoria #
all - tutte 129.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.291 0 0 0 0 39 14 93 87 13 110 325 610
2022/20234.756 385 349 164 425 414 454 79 288 1.956 41 142 59
2023/20241.122 106 197 57 91 132 261 0 107 3 48 15 105
2024/20255.518 82 111 116 332 265 132 35 1.493 1.485 256 432 779
2025/202615.351 626 1.106 1.408 1.117 1.146 3.605 1.876 1.747 1.709 569 248 194
2026/20272.793 278 712 694 1.096 13 0 0 0 0 0 0 0
Totale 37.214